Anika Therapeutics, Inc. Deferred Tax Assets, Deferred Income
Anika Therapeutics, Inc. (ANIK) had Deferred Tax Assets, Deferred Income of $23.85 thousand as of 2014-12-31, per its 10-K filed 2015-03-13.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsDeferredIncome · last filed 2015-03-13
- 2014-12-31: Deferred Tax Assets, Deferred Income $23.85K.
- 2013-12-31: Deferred Tax Assets, Deferred Income $852.21K.
- 2012-12-31: Deferred Tax Assets, Deferred Income $1.99M.
- 2011-12-31: Deferred Tax Assets, Deferred Income $2.07M.
| Period end | Deferred Tax Assets, Deferred Income |
|---|---|
| 2014-12-31 | $23.85K 10-K · filed 2015-03-13 |
| 2013-12-31 | $852.21K 10-K · filed 2015-03-13 |
| 2012-12-31 | $1.99M 10-K · filed 2014-03-13 |
| 2011-12-31 | $2.07M 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |